4 completed, 1 enrolling by invitation, 1 terminated. 3 Phase 3, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Enrolling by invitation 1, Terminated 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow ralinepag: new trials by email Literature Review of ralinepag trials Research Report on ralinepag
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects Ralinepag, Placebo - Pulmonary Hypertension, Pulmonary Arterial Hypertension | Phase 3 | Terminated | United Therapeutics | 10 | 2021-01-20 | 2026-07-06 |
| A Study of Ralinepag in Healthy Chinese Adult Subjects Ralinepag - Healthy Volunteer, Pharmacokinetic Study | Phase 1 | Completed | Everstar Medicines (Shanghai) Limited | 15 | 2020-10-09 | 2024-02-01 |
| A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension Ralinepag - PAH, Pulmonary Hypertension | Phase 3 | Enrolling by invitation | United Therapeutics | 1000 | 2019-09-23 | 2026-10-06 |
| A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients Ralinepag, Placebo - PAH, Pulmonary Hypertension | Phase 3 | Completed | United Therapeutics | 687 | 2019-01-24 | 2026-06-16 |
| Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension Ralinepag - Pulmonary Arterial Hypertension | Phase 2 | Completed | United Therapeutics | 45 | 2015-07-08 | 2021-12-22 |
| Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension APD811, Placebo - Pulmonary Arterial Hypertension | Phase 2 | Completed | United Therapeutics | 61 | 2014-12-01 | 2020-07-14 |
Pulmonary Arterial Hypertension (5) · Hypertension, Pulmonary (3) · Cardiovascular Diseases (2) · Connective Tissue Diseases (2) · Familial Primary Pulmonary Hypertension (2) · Hypertension (2) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Vascular Diseases (2)
United Therapeutics (5) · Everstar Medicines (Shanghai) Limited (1)
Australia (5) · Poland (5) · Spain (5) · United States (5) · Bulgaria (4) · Czechia (4) · Hungary (4) · Romania (4) · Serbia (4) · Argentina (3) · Austria (3) · Belgium (3) · Brazil (3) · Canada (3) · China (3)
Derek Solum, PhD (1) · Haiyan Li (1)